Keywords: عامل رشد اپیوئید; Opioid growth factor; Spinal cord; Astrogliosis; Microglial proliferation; Inflammation; Relapse-remitting experimental autoimmune encephalomyelitis;
مقالات ISI عامل رشد اپیوئید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy
Keywords: عامل رشد اپیوئید; LDN; low dose naltrexone; OGFr; opioid growth factor receptor; OGF; opioid growth factor; FDA; Food and Drug Administration; HDN; high dose naltrexone; TLR-4; Toll like Receptor 4; BMDCs; bone marrow dendritic cells; MENK; methionine enkephalin; MS; multi
Selective opioid growth factor receptor antagonists based on a stilbene isostere
Keywords: عامل رشد اپیوئید; Opioid receptor; Opioid growth factor; Low-dose naltrexone; Pawhuskin; Stilbene isostere;
Expression of the opioid growth factor-opioid growth factor receptor axis in human ovarian cancer
Keywords: عامل رشد اپیوئید; Ovarian cancer; Opioid growth factor;
Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models
Keywords: عامل رشد اپیوئید; Naltrexone hydrochloride; Opioid growth factor; Niosomes; Bovine cornea; Ocular delivery
Research ReportOpioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis
Keywords: عامل رشد اپیوئید; Multiple sclerosis; Astroctyes; Proliferation; Opioid growth factor; Opioid growth factor receptor; MOG-induced disease; Behavior;
The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice
Keywords: عامل رشد اپیوئید; Ovarian cancer; Opioids; Enkepalins; Xenografts; Opioid growth factor; Low dose naltrexone
B lymphocyte proliferation is suppressed by the opioid growth factor–opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases
Keywords: عامل رشد اپیوئید; Cell proliferation; Cyclin-dependent kinase inhibitor; [Met5]-enkephalin; Opioid growth factor; OGFr; T lymphocyte
Research ReportPrevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis
Keywords: عامل رشد اپیوئید; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Opioid; Opioid growth factor; Opioid growth factor receptor; Autoimmune diseases; EAE; experimental autoimmune encephalomyelitis; MS; multiple sclerosis; OGF; opioid growth factor; OGFr; opioi
T lymphocyte proliferation is suppressed by the opioid growth factor ([Met5]-enkephalin)–opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases
Keywords: عامل رشد اپیوئید; Cell proliferation; Cyclin dependent kinase inhibitor; [Met5]-enkephalin; Opioid growth factor; OGFr; T lymphocyte
Opioid growth factor suppresses expression of experimental autoimmune encephalomyelitis
Keywords: عامل رشد اپیوئید; EAE; experimental Autoimmune Encephalomyelitis; MS; Multiple Sclerosis; OGF; Opioid Growth Factor; OGFr; Opioid Growth Factor Receptor; MOG; myelin oligodendrocyte glycoprotein; CFA; complete Freund's adjuvant; GFAP; glial fibrillary acidic protein; PHA;